Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure
NCT ID: NCT01951443
Last Updated: 2014-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
24 participants
INTERVENTIONAL
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation
NCT00730951
Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation
NCT00728221
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
NCT06236243
Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension
NCT02211352
Effect of Ginseng on Blood Pressure
NCT01913210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ginseng
Encapsulated 400mg Rg3-KRG extract
Ginseng
400mg of encapsulated Rg3-KRG
Wheat Bran
400mg Wheat Bran capsule
Wheat Bran
400mg of encapsulated wheat bran
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginseng
400mg of encapsulated Rg3-KRG
Wheat Bran
400mg of encapsulated wheat bran
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-70 years
* BMI \< 30 kg/m2
* Brachial systolic blood pressure \< 140 mmHg
* Brachial diastolic blood pressure \< 90 mmHg
Exclusion Criteria
* Hypertensive (brachial systolic BP ≥140mmHg and/or diastolic BP ≥90mmHg)
* Pregnancy
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Vladimir Vuksan, PhD
Role: PRINCIPAL_INVESTIGATOR
Risk Factor Modification Centre - St. Michael's Hospital
Dr. Amir Hanna (Qualified investigator), MD
Role: PRINCIPAL_INVESTIGATOR
Unity Health Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Risk Factor Modification Centre, St. Michael's Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KRAB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.